Specialized CDMO Moravek’s focus on GMP carbon-14 labeled APIs and radiosynthesis positions them as a niche CDMO for early-phase clinical trials, presenting opportunities to partner with biotech and pharma companies needing compliant radiolabeled compounds.

Global Research Access With over 45 years in the field and a worldwide research customer base, there is potential to expand collaborations with mid to large pharma, biotech and academic institutions seeking reliable radiolabeling services and preclinical supply.

Scale & Compliance Revenue in the mid-range and FDA ICH Q7 compliance capability highlight a proven track record; sales pursuits can emphasize reliability, quality systems, and scalable radiolabeling workflows to justify pilot-to-GLP/early-phase transitions.

RADIOLOGIST NETWORK Moravek’s catalog of non-GMP and non-labeled radiolabeled and stable-labeled compounds offers upsell opportunities to laboratories, CROs, and academic groups needing readily available research materials for method development and sourcing.

Digital & Security Edge Tech stack including Cloudflare and enterprise collaboration tools signals modern infrastructure; present value to potential customers by highlighting secure data handling, IP protection, and efficient project management in radiolabeling programs.